NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.
NCCN Guidelines® Insights: Gastrointestinal Stromal Tumors, Version 2.2022.
复制标题
DOI:
10.6004/jnccn.2022.0058
复制
发表时间:
2022-11
期刊:
影响因子:
--
通讯作者:
Hang LE
中科院分区:
文献类型:
--
作者:
von Mehren M;Kane JM;Riedel RF;Sicklick JK;Pollack SM;Agulnik M;Bui MM;Carr-Ascher J;Choy E;Connelly M;Dry S;Ganjoo KN;Gonzalez RJ;Holder A;Homsi J;Keedy V;Kelly CM;Kim E;Liebner D;McCarter M;McGarry SV;Mesko NW;Meyer C;Pappo AS;Parkes AM;Petersen IA;Poppe M;Schuetze S;Shabason J;Spraker MB;Zimel M;Bergman MA;Sundar H;Hang LE
Gastrointestinal stromal tumors (GIST) are the most common type of soft tissue sarcoma that occur throughout the gastrointestinal tract. Most of these tumors are caused by oncogenic activating mutations in the KIT or PDGFRA genes. The NCCN Guidelines for GIST provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with these tumors. These NCCN Guidelines Insights summarize the panel discussion behind recent important updates to the guidelines, including revised systemic therapy options for unresectable, progressive, or metastatic GIST based on mutational status, and updated recommendations for the management of GIST that develop resistance to specific tyrosine kinase inhibitors.
登录
查看更多内容
影响因子:
3.7
作者:
Agaram, Narasimhan P.;Wong, Grace C.;Guo, Tianhua;Maki, Robert G.;Singer, Samuel;DeMatteo, Ronald P.;Besmer, Peter;Antonescu, Cristina R.
通讯作者:
Antonescu, Cristina R.
影响因子:
45.3
作者:
Corless, CL;Fletcher, JA;Heinrich, MC
通讯作者:
Heinrich, MC
影响因子:
8.4
作者:
Debiec-Rychter, M;Dumez, H;van Oosterom, AT
通讯作者:
van Oosterom, AT
影响因子:
2.9
作者:
Kefeli U;Benekli M;Sevinc A;Yildiz R;Kaplan MA;Ciltas A;Balakan O;Isikdogan A;Coskun U;Dane F;Harputluoglu H;Karaca H;Yazilitas D;Durnali A;Kaya AO;Demirci U;Gumus M;Buyukberber S
通讯作者:
Buyukberber S
影响因子:
50.5
作者:
Ben-Ami, E.;Barysauskas, C. M.;George, S.
通讯作者:
George, S.